Protective effect of L-arginine against nephrotoxicity induced by cyclosporine in normal rats

Pharmacological Research

Volumn 45, Issue 6, 2002, Pages 441-446

  Mansour, Mahmoud ^a   Hesham Daba, Mohammad ^b   Gado, Ali ^a   Al Rikabi, Ammar ^b   Al Majed, Abdulhakeem ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Aminoguanidine; Cyclosporine; L arginine; Nephrotoxicity; Oxidative stress

Indexed keywords

AMINOGUANIDINE; ARGININE; CYCLOSPORIN; GLUTATHIONE PEROXIDASE; LIPID PEROXIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HISTOPATHOLOGY; KIDNEY DYSFUNCTION; KIDNEY PARENCHYMA; MALE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REDUCTION; UREA BLOOD LEVEL;

EID: 0036423663     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1006/phrs.2002.0968     Document Type: Article

References (33)

1. Jackson NM, Hsu CH, Visscher GE, Venkatachalam MA, Humes HD. Alteractions in renal structure and function in a rat model of cyclosporin nephrotoxicity. J Pharmacol Exp Ther 1987; 242: 749-56.
2. Andoh TF, Gardner MP, Bennett WM. Protective effects of dietary L-arginine supplementation on chronic cyclosporine nephrotoxicity. Transplantation 1997; 64: 1236-40.
3. Naidu MU, Kumar JV, Shifow AA, Prayag A, Ratnakar KS. Lacidipine protects against cyclosporine induced nephrotoxicity in rats. Nephron 1999; 81: 60-6.
4. Bloom IT, Bentley FR, Spain DA, Garrison RN. An experimental study of altered nitric oxide metabolism as a mechanism of cyclosporine induced renal vasconstriction. Br J Surg 1995; 82: 195-8.
5. Bobadilla NA, Tapia E, Franco M, Lopez P, Mendoza S, Garcia-Torres R, Alvarado JA, Herrera-Acosta J. Role of nitric oxide in renal hemodynamic abnormalities of cyclosporine nephrotoxicity. Kidney Int 1994; 46: 773-9.
6. Keown PA, Stiller CR. Cyclosporine-allograft rejection. In: Textbook of Nephrology. 2nd Edn, vol. 2, Massry SG, Glassack RJ, eds. Baltimore: Williams & Wilkins, 1995: 1648-55.
7. Amore A, Gianglio B, Ghigo D, Peruzzi L, Porcellini MG, Bussolino F et al. A possible role for nitric oxide in modulating the functional cyclosporine toxicity by arginine. Kidney Int 1995; 47: 1507-14.
8. Serino F, Grevel J, Napoli KL, Kahan BD, Strobel HW. Oxygen radical formation by the cytochrome P450 system as a cellular mechanism for cyclosporin toxicity. Transplant Proc 1994; 26: 2916-7.
9. Wolf A, Cleman N, Frieauff W, Ryffel B, Cordier A. Role of reactive oxygen formation in the cyclosporine mediated impairment of renal functions. Transplant Proc 1994; 16: 2902-7.
10. de-Belder AJ, Radomski MW. Nitric oxide in the clinical arena. J Hypertension 1994; 12: 617-24.
11. Misko TP, Moore WM, Kasten TP, Nickols GA, Corbett JA, Tilton RG, McDaniel L, Williamson JR, Currie M. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur J Pharmacol 1993; 233: 119-25.
12. Cernadas M, Lopez-Farre A, Riesco A, Gallego M, Espinosa G, Digiuni E, Hernando L, Casado S, Caramelo C. Renal and systemic effects of amino acids administered separately: Comparison between L-arginine and non nitric oxide donor amino acids. J Pharmacol Exp Ther 1992; 263: 1023-9.
13. Bhardwaj R, Moore PK. The effect of arginine and nitric oxide on resistance blood vessels of the perfused rat kidney. Br J Pharmacol 1989; 97: 739-44.
14. Tilton RG et al. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation. Diabetes 1993; 42: 221-31.
15. Sugimoto K, Yagihashi S. Effects of aminoguanidine on structural alterations of microvessels in peripheral nerve of streptozotocin diabetic rats. Microvasc Res 1997; 53: 105-12.
16. Ihm SH, Yoo HJ, Park SW, Ihm J. Effect of aminoguanidine on lipid peroxidation in streptozotocin-induced diabetic rats. Metabolism 1999; 48: 1141-5.
17. Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997; 272: 9030-6.
18. Li Q, Bowmer C, Yates M. Effect of arginine on cisplatin - Induced acute renal failure in rat. Biochem Pharmacol 1994; 47: 2298-301.
19. Yang CW, Kim YS, Kim J, Kim YO, Min SY, Choi EJ, Bang BK. Oral supplementation of L-arginine prevents chronic cyclosporine nephrotoxicity in rats. Exp Nephrol 1998; 6: 50-6.
20. Lassila M, Santisteban J, Finckenberg P, Salmenpera P, Riutta A, Moilanen E, Virtanen I, Vapaatalo H, Nurminen ML. Vascular changes in cyclosporine A-induced hypertension and nephrotoxicity in spontaneously hypertensive rats on high-sodium diet. J Physiol Pharmacol 2001; 52: 21-8.
21. Aoki K, Ohmori M, Takimoto M, Ota H, Yoshida T. Cocaine-induced liver injury in mice is mediated by nitric oxide and reactive oxygen species. Eur J Pharmacol 1997; 336: 43-9.
22. Gardner CR, Heck DE, Yang CS, Thomas PE, Zhang XJ, DeGeorge GL, Laskin JD, Laskin D. Role of nitric oxide in acetominophen-induced hepatotoxicity in the rat. Hepatology 1998; 27: 748-54.
23. Bartles H, Bohmer M, Heieri C. Serum kreatininbestimmung ohne enteiweissen. Clin Chim Acta 1972; 37: 193-7.
24. Patton CJ, Crouch SR. Spectrophotometric and kinetics investigation of the Berthelot reaction for the determination of ammonia. Anal Chem 1977; 49: 464-9.
25. Ellman GL. Tissue sulfahydryl groups. Arch Biochem Biophys 1959; 82: 70-7.
26. Ohkawa H, Ohishi N, Yagi K. Assay of lipid peroxides in normal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-8.
27. Kraus RJ, Ganther HE. Reaction of cyanide with glutathione peroxidase. Biochem Biophys Res Commun 1980; 1696: 1116-22.
28. Assis SM, Monteiro JL, Seguro AC. L-arginine and allopurinol protect against cyclosporine nephrotoxicity. Transplantation 1997; 63: 1070-3.
29. De Nicola L, Thomson SC, Wead LM, Brown MR, Gabbai FB. Arginine feeding modifies cyclosporine nephrotoxicity in rats. J Clin Invest 1993; 92: 1859-65.
30. Oriji GK, Keiser HR. Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 1998; 32: 849-55.
31. Zhang XZ, Ardissino G, Ghio L, Tirelli AS, Dacco V, Colombo D, Pace E, Testa S, Claris-Appiani A. L-arginine supplementation in young renal allograft recipients with chronic transplant dysfunction. Clin Nephrol 2001; 55: 453-9.
32. Amore A, Emancipator SN, Cirina P, Conti G, Ricotti E, Bagheri N, Coppo R. Nitric oxide mediates cyclosporine-induced apoptosis in cultured renal cells. Kidney Int 2001; 57: 1549-59.
33. Wu MS, Yang CW, Bens M, Yu HM, Huang JY, Wu CH, Huang CC, Vandewalle A. Cyclosporine inhibits nitric oxide production in medullary ascending limb cultured cells. Nephrol Dial Transplant 1998; 13: 2814-20.